Dichlorophenol HSD17B13 inhibitors and uses thereof
US11827619B2 · kind B2 · utility
1Cited by
1References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2023 |
| Grant date | Nov 28, 2023 |
| Priority date | — |
| Expiry date | May 10, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.